Publications by Dr Ashleigh Herriott - ePrints

Newcastle Authors	Title	Year
Lucy Gentles Bojidar Goranov Elizabeth Matheson Dr Ashleigh Herriott Dr Angelika Kaufmann et al.	Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types	2019
Dr Ashleigh Herriott Dr Miranda Patterson Professor Nicola Curtin	Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers	2017
Fiona Middleton Dr Miranda Patterson Dr Claire Elstob Dr Sarah Fordham Dr Ashleigh Herriott et al.	Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition	2015
Dr Ashleigh Herriott Dr Susan Tudhope Gesa Junge Natalie Rodrigues Dr Miranda Patterson et al.	PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia	2015
Dr Jun-yong Huang Dr Ashleigh Herriott	A deficiency of the Cdk1 phosphorylation of fizzy increases the binding affinity to cyclin B and reduces the affinities to BubR1 and Mad2 in Drosophila melanogaster	2013
Dr Ashleigh Herriott Dr Michele Sweeney Emeritus Professor Michael Whitaker Professor Michael Taggart Dr Jun-yong Huang et al.	Kinetochore localized Mad2 and Cdc20 is itself insufficient for triggering the mitotic checkpoint when Mps1 is low in Drosophila melanogaster neuroblasts	2012